Dividend stock is the term for a stock which the
company pays dividends in large amount, say more than half of its net profit in
a given year, while on the other hand, the price of the stock is not too high
so that its dividend yield are greater than other stocks in general. Example? Bank
BJB (BJBR). Since the year 2007 to 2013, BJBR always pay dividends by an
average of 65% of its net income each year. For the book of 2013, the dividend
was Rp78 per share. With the price of Rp965 per share before the cum date, then
the dividend yield of BJBR was 965 / 78 = 0.081, or 8.1%. This figure is quite
large when compared with yield of blue chip stocks, which only 2 – 4% in
average.
You can contact the author (Teguh Hidayat) by email, teguh.idx@gmail.com. The author live in Jakarta, Indonesia.
See my activities in Instagram, @teguhidx.
Outlook of Pharmaceutical Stocks related to Healthcare
In addition to the sector of construction which we’ve discussed last week, in
the last fe days I often receive questions (by email) about the prospect of
Kalbe Farma (KLBF), Tempo Scan Pacific (TSPC), etc., aka pharmaceutical stocks,
related to the government program that called Social Security of Health (Badan Penyelenggara Jaminan Sosial Kesehatan,
or BPJS Kesehatan, it’s more and
less similar to Obama’s Healthcare), which has been running since the beginning
of 2014. Then, after Jokowi sworn in as President on 20 October yesterday,
shortly afterwards he launched his program of 'magic cards', one of which called
Indonesia Healthy Card (Kartu Indonesia
Sehat, or KIS), which may make
you curious, how about its impact on the stocks of pharmaceutical in Indonesia
Stock Exchange (IDX). Well, before that, let us first discuss the theme of
'health' from the beginning.
Subscribe to:
Posts (Atom)